Consolidated Statement of Operation Statement (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Net sales and revenues
Sales of goods	$ 970	$ 5,489
Contract research and service revenues	2,268	1,986
Total net sales and revenues	3,238	7,475
Cost of sales and revenues
Cost of goods sold	1,791	4,288
Cost of contract research and services	1,222	1,234
Total cost of sales and revenues	3,013	5,522
Gross margin	225	1,953
Operating expenses
Selling, general and administrative expenses	2,814	3,464
Internal research and development expenses	13	98
Total operating expenses	2,827	3,562
Operating loss from continuing operations	(2,602)	(1,609)
Interest expense, net	(16)	(31)
Foreign exchange gain (loss)	(8)	2
Total other expense, net	(24)	(29)
Loss from continuing operations before income tax benefit (provision)	(2,626)	(1,638)
Income tax benefit (provision) - continuing operations	(2)	1,992
Loss from continuing operations	(2,628)	354
Loss from discontinued operations before sale of business unit	0	(430)
Gain on sale of business unit, net of transaction expenses	0	5,449
Income tax provision - discontinued operations	0	(2,008)
Income (loss) from discontinued operations, net of tax	0	3,011
Net loss	$ (2,628)	$ 3,365
Basic income (loss) per share:
From continuing operations, net of tax	$ (0.29)	$ 0.04
From discontinued operations, net of tax	$ 0.00	$ 0.35
Basic loss per share	$ (0.29)	$ 0.39
Diluted income (loss) per share:
From continuing operations, net of tax	$ (0.29)	$ 0.04
From discontinued operations, net of tax	$ 0.00	$ 0.35
Diluted loss per share	$ (0.29)	$ 0.39
Weighted average number of common and common equivalent shares outstanding – basic (in shares)	9,080,385	8,562,633
Weighted average number of common and common equivalent shares outstanding – diluted	9,080,385	8,565,487